Results 241 to 250 of about 413,528 (329)

Behavioral Intelligence in Action: Implementation Science and Cardiovascular Learning Health Systems. [PDF]

JACC Adv
Mizuno A, Ahmad FS, Brahmbhatt DH.
europepmc   +1 more source

Gut microbiota‐related modulation of immune mechanisms in post‐infarction remodelling and heart failure

ESC Heart Failure, Volume 12, Issue 2, Page 942-954, April 2025.
Abstract The immune system has long been recognized as a key driver in the progression of heart failure (HF). However, clinical trials targeting immune effectors have consistently failed to improve patient outcome across different HF aetiologies. The activation of the immune system in HF is complex, involving a broad network of pro‐inflammatory and ...
Johann Roessler, Friederike Zimmermann, Bettina Heidecker, Ulf Landmesser, Arash Haghikia   +4 more
wiley   +1 more source

Effectiveness of bivalent respiratory syncytial virus prefusion F protein-based vaccine in individuals with or without atherosclerotic cardiovascular disease: the DAN-RSV trial. [PDF]

Eur Heart J
Pareek M, Lassen MCH, Johansen ND, Christensen SH, Aliabadi N, Skaarup KG, Modin D, Claggett BL, Larsen CS, Larsen L, Wiese L, Dalager-Pedersen M, Lindholm MG, Jensen AMR, Dons M, Bernholm KF, Davidovski FS, Duus LS, Ottosen CI, Nielsen AB, Borchsenius JH, Espersen C, Köse G, Fussing FH, Køber L, Solomon SD, Jensen JUS, Martel CJ, Gessner BD, Schwarz C, Gonzalez E, Skovdal M, Zhang P, Begier E, Biering-Sørensen T.   +34 more
europepmc   +1 more source

Incident heart failure: comparing management and outcome in primary and hospital settings in Western Sweden 2008–2017

ESC Heart Failure, Volume 12, Issue 2, Page 832-838, April 2025.
Abstract Aim Heart failure (HF) is a highly prevalent condition managed in both primary care (PC) and hospital care (HC)‐based settings. HF patients managed in these two settings may differ in their demography, comorbidities and outcomes, so we aimed to compare the patient management in PC and HC in the Västra Götaland Region (VGR) in Sweden.
Xiaojing Chen, Aldina Pivodic, Maria Schaufelberger, Annika Rosengren, Michael Fu   +4 more
wiley   +1 more source

Comparative Efficacy of Noradrenaline vs. Other Vasopressors on Outcomes in Patients With Cardiogenic Shock　- A Systematic Review and Meta-Analysis. [PDF]

Circ Rep
Hosoya Y, Yamamoto M, Hanada H, Osawa T, Arai M, Sakamoto K, Okazaki Y, Katasako-Yabumoto A, Ishizu T, Kondo T, Kirigaya J, Nakayama N, Yamamoto T, Hashiba K, Nakashima T, Noguchi T, Tsujimoto Y, Kikuchi M, Funazaki T, Tahara Y, Nonogi H, Matoba T, Japan Resuscitation Council (JRC) Emergency Cardiovascular Care (ECC) Cardiogenic Shock (CS) Task Force and the Guideline Editorial Committee on behalf of the Japanese Circulation Society (JCS) Emergency and Critical Care Committee.   +22 more
europepmc   +1 more source

MELD score predicts outcomes in patients with advanced heart failure: A longitudinal evaluation

ESC Heart Failure, Volume 12, Issue 2, Page 839-847, April 2025.
Abstract Aims Advanced heart failure (AHF) is characterized by recurrent episodes of haemodynamic instability and frequent hospitalizations, leading to a progressive decline in quality of life and high mortality rates. The objectives of this study were to evaluate the effect of the model for end‐stage liver disease (MELD) score and its variations in ...
Francesco Curcio, Cristiano Amarelli, Rosaria Chiappetti, Irene Mattucci, Veronica Flocco, Mahmoud Issa Rammal, Ciro Abete, Francesca Mazzella, Ciro Maiello, Pasquale Abete, Francesco Cacciatore   +10 more
wiley   +1 more source

When more is worse: aspirin backfires in anticoagulated post-PCI patients. [PDF]

Eur Heart J Cardiovasc Pharmacother
Gragnano F, Galli M, Calabrò P, Grove EL.   +3 more
europepmc   +1 more source

Transthyretin amyloid cardiomyopathy: Literature review and red‐flag symptom clusters for each cardiology specialty

ESC Heart Failure, Volume 12, Issue 2, Page 955-967, April 2025.
Abstract Wild‐type transthyretin amyloid cardiomyopathy (ATTRwt‐CM) is a progressive and infiltrative cardiac disorder that may cause fatal consequences if left untreated. The estimated survival time from diagnosis is approximately 3–6 years. Because of the non‐specificity of initial symptom manifestation and insufficient awareness among treating ...
Yasuhiro Izumiya, Toru Kubo, Jin Endo, Seiji Takashio, Masatoshi Minamisawa, Jun Hamada, Tomonori Ishii, Hajime Abe, Hiroaki Konishi, Kenichi Tsujita   +9 more
wiley   +1 more source

The assessment and management of patients with type 2 myocardial infarction: an international Delphi study. [PDF]

Eur Heart J Qual Care Clin Outcomes
Taggart C, Ferry AV, Chapman AR, Schulberg SD, Bularga A, Wereski R, Boeddinghaus J, Kimenai DM, Lowry MTH, Chew DP, Cullen L, Daniels LB, Devereaux PJ, French J, Gaggin HK, Huynh T, Jacquin L, Jaffe AS, Jernberg T, Koronowski R, McCarthy C, McCord J, Mamas MA, Mickley H, Morrow DA, Mueller C, Newby LK, Parsonage W, Raphael CE, Smer A, Smith SW, Sandoval Y, Smilowitz NR, White H, Eggers KM, Lindahl B, Thygesen K, Mills NL.   +37 more
europepmc   +1 more source